![EJBPS - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal of Biomedical and Pharmaceutical Sciences EJBPS - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal of Biomedical and Pharmaceutical Sciences](https://www.ejbps.com/assets/images/welcome_img.png)
EJBPS - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal of Biomedical and Pharmaceutical Sciences
![Khutoryanskiy group on X: "Our new paper "Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro" in Eur J Pharm Sci https://t.co/X6LDvf9Vv3 Khutoryanskiy group on X: "Our new paper "Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro" in Eur J Pharm Sci https://t.co/X6LDvf9Vv3](https://pbs.twimg.com/media/DhCIXhGWsAImWbm.jpg)
Khutoryanskiy group on X: "Our new paper "Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro" in Eur J Pharm Sci https://t.co/X6LDvf9Vv3
![EJPMR - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal Pharmaceutical And Medical Research EJPMR - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal Pharmaceutical And Medical Research](https://www.ejpmr.com/assets/front/images/EJPMR_Impact_Factor.jpeg)
EJPMR - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal Pharmaceutical And Medical Research
![EJBPS - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal of Biomedical and Pharmaceutical Sciences EJBPS - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal of Biomedical and Pharmaceutical Sciences](https://www.ejbps.com/assets/images/ejbps_ugc.jpg)
EJBPS - A Journal Following UGC Guidelines - Refereed Journal - Peer Reviewed Journal - European Journal of Biomedical and Pharmaceutical Sciences
A review article just published in the European Journal of Pharmaceutical Sciences: a great collaborative effort
![Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases,European Journal of Pharmaceutical Sciences - X-MOL Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases,European Journal of Pharmaceutical Sciences - X-MOL](https://xpic.x-mol.com/20231127%2F10.1016_j.ejps.2023.106647.jpg)
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases,European Journal of Pharmaceutical Sciences - X-MOL
![PDF) Corrigendum to 'Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation': European Journal of Pharmaceutical Sciences Volume 177 (2022) 106268 PDF) Corrigendum to 'Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation': European Journal of Pharmaceutical Sciences Volume 177 (2022) 106268](https://i1.rgstatic.net/publication/364364280_Corrigendum_to_'Evidence_of_the_need_for_modified_well-stirred_model_in_vitro_to_in_vivo_extrapolation'_European_Journal_of_Pharmaceutical_Sciences_Volume_177_2022_106268/links/64a7b02ab9ed6874a501d07d/largepreview.png)
PDF) Corrigendum to 'Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation': European Journal of Pharmaceutical Sciences Volume 177 (2022) 106268
![Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL](https://xpic.x-mol.com/20230917%2F10.1016_j.ejps.2023.106578.jpg)
Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL
![PDF) Novel Nitroxide-Bile Acid Conjugates Inform Substrate Requirements for Human Bile Acid Transporters PDF) Novel Nitroxide-Bile Acid Conjugates Inform Substrate Requirements for Human Bile Acid Transporters](https://i1.rgstatic.net/publication/365463480_Novel_Nitroxide-Bile_Acid_Conjugates_Inform_Substrate_Requirements_for_Human_Bile_Acid_Transporters/links/6404e9c00d98a97717dceec7/largepreview.png)
PDF) Novel Nitroxide-Bile Acid Conjugates Inform Substrate Requirements for Human Bile Acid Transporters
![Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL](https://xpic.x-mol.com/20230420%2F10.1016_j.ejps.2023.106448.jpg)
Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL
![Elsevier Pharma on X: "The European Journal of Pharmaceutical Sciences is delighted to announce the winner of the EJPS 2020 Best Paper Award - Congrats to Tatiane Cogo Machado, Gislaine Kuminek, Simone Elsevier Pharma on X: "The European Journal of Pharmaceutical Sciences is delighted to announce the winner of the EJPS 2020 Best Paper Award - Congrats to Tatiane Cogo Machado, Gislaine Kuminek, Simone](https://pbs.twimg.com/media/E16B8t7XEAUo9je.png)